Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.

× No keyword cloud information.

16 in total

1. Treatment of recurrent retinal angiomatous proliferation with intravitreal triamcinolone acetonide followed by photodynamic therapy with verteporfin: A retrospective case series.

Authors: Nicola Cardascia; Claudio Furino; Andrea Ferrara; Francesco Boscia; Giovanni Alessio
Journal: Curr Ther Res Clin Exp Date: 2009-06

2. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.

Authors: Ilse Krebs; Katharina Krepler; Ulrike Stolba; Alexandra Goll; Susanne Binder
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2007-08-03 Impact factor: 3.117

Review 3. [Photodynamic therapy in AMD. Strategy for indication].

Authors: D Pauleikhoff; G Spital
Journal: Ophthalmologe Date: 2004-12 Impact factor: 1.059

4. Prognosis of untreated occult choroidal neovascularization.

Authors: Ilse Krebs; Ulrike Stolba; Carl Glittenberg; Orang Seyeddain; Thomas Benesch; Susanne Binder
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2006-10-27 Impact factor: 3.117

5. Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.

Authors: T A Ciulla; M H Criswell; W J Snyder; W Small
Journal: Br J Ophthalmol Date: 2005-01 Impact factor: 4.638

6. Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

Authors: Clement K Chan; Atul Jain; Srinivas Sadda; Neeta Varshney
Journal: Trans Am Ophthalmol Soc Date: 2014-07

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.

1. Treatment of recurrent retinal angiomatous proliferation with intravitreal triamcinolone acetonide followed by photodynamic therapy with verteporfin: A retrospective case series.

2. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.

Review 3. [Photodynamic therapy in AMD. Strategy for indication].

4. Prognosis of untreated occult choroidal neovascularization.

5. Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.

6. Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

7. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.

Review 8. Radiotherapy for neovascular age-related macular degeneration.

Review 9. Current and future treatment options for nonexudative and exudative age-related macular degeneration.

Review 10. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.